Adimmune Corporation (TPE:4142)
Taiwan · Delayed Price · Currency is TWD 18.50
-0.20 (-1.07%)
Apr 17, 2026, 1:30 PM CST
Adimmune Market Cap
Adimmune has a market cap or net worth of 7.8 billion as of April 17, 2026. Its market cap has decreased by -16.29% in one year.
Market Cap
7.80B
Enterprise Value
8.52B
Revenue
1.40B
Ranking
n/a
PE Ratio
n/a
Stock Price
18.50
Market Cap Chart
Since September 29, 2010, Adimmune's market cap has decreased from 11.10B to 7.80B, a decrease of -29.73%. That is a compound annual growth rate of -2.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 7.80B | -2.37% |
| Dec 31, 2025 | 7.99B | -5.72% |
| Dec 31, 2024 | 8.47B | -39.37% |
| Dec 29, 2023 | 13.97B | -7.97% |
| Dec 30, 2022 | 15.18B | -20.83% |
| Dec 30, 2021 | 19.18B | -20.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tanvex BioPharma | 10.78B |
| Locus Cell | 9.75B |
| PharmaEngine | 8.46B |
| Gongwin Biopharm Holdings | 8.34B |
| TaiGen Biopharmaceuticals Holdings | 7.76B |
| Acepodia | 7.04B |
| Mycenax Biotech | 6.29B |
| Savior Lifetec | 6.18B |